Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy
Article in The Breast (November 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in The Breast (November 2023)
Article in Oncologie (September 2022)
Preprint in Research Square (June 2022)